| Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial R Bartsch, AS Berghoff, J Furtner, M Marhold, ES Bergen, S Roider-Schur, ... Nature medicine 28 (9), 1840-1847, 2022 | 193 | 2022 |
| HIF1α regulates mTOR signaling and viability of prostate cancer stem cells M Marhold, E Tomasich, A El-Gazzar, G Heller, A Spittler, R Horvat, ... Molecular Cancer Research 13 (3), 556-564, 2015 | 145 | 2015 |
| Effects of resistance exercise in prostate cancer patients: a meta-analysis M Keilani, T Hasenoehrl, L Baumann, R Ristl, M Schwarz, M Marhold, ... supportive Care in Cancer 25, 2953-2968, 2017 | 109 | 2017 |
| The effects of resistance exercise on physical performance and health-related quality of life in prostate cancer patients: a systematic review T Hasenoehrl, M Keilani, T Sedghi Komanadj, M Mickel, M Margreiter, ... Supportive Care in Cancer 23, 2479-2497, 2015 | 74 | 2015 |
| TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo P Horak, E Tomasich, P Vaňhara, K Kratochvílová, M Anees, M Marhold, ... Scientific reports 4 (1), 3739, 2014 | 71 | 2014 |
| Human microbiota and breast cancer—is there any relevant link?—a literature review and new horizons toward personalised medicine D Alpuim Costa, JG Nobre, MV Batista, C Ribeiro, C Calle, A Cortes, ... Frontiers in microbiology 12, 584332, 2021 | 68 | 2021 |
| SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers C Altenberger, G Heller, B Ziegler, E Tomasich, M Marhold, T Topakian, ... Molecular cancer 16, 1-12, 2017 | 37 | 2017 |
| Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia J Stangl-Kremser, R Suarez‐Ibarrola, DD Andrea, SM Korn, M Pones, ... Prostate Cancer and Prostatic Diseases 23 (2), 309-315, 2020 | 36 | 2020 |
| DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancers G Heller, C Altenberger, B Schmid, M Marhold, E Tomasich, B Ziegler, ... Oncotarget 6 (1), 394, 2015 | 28 | 2015 |
| Immune checkpoint inhibitors in mCRPC-rationales, challenges and perspectives H Taghizadeh, M Marhold, E Tomasich, S Udovica, A Merchant, M Krainer Oncoimmunology 8 (11), e1644109, 2019 | 26 | 2019 |
| 280P Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: results from the first stage of the phase II … R Bartsch, AS Berghoff, J Furtner, ES Bergen, S Roider-Schur, M Marhold, ... Annals of Oncology 32, S486, 2021 | 25 | 2021 |
| Strength of skeletal muscle and self-reported physical performance in Austrian glioblastoma-patients. M Keilani, C Krall, C Marosi, B Flechl, K Dieckmann, G Widhalm, ... Wiener klinische Wochenschrift 124, 2012 | 23 | 2012 |
| Neuromuscular electrical stimulation of the thighs in cardiac patients with implantable cardioverter defibrillators F Cenik, D Schoberwalter, M Keilani, B Maehr, M Wolzt, M Marhold, ... Wiener Klinische Wochenschrift 128, 802-808, 2016 | 22 | 2016 |
| Synthetic lethality guiding selection of drug combinations in ovarian cancer A Heinzel, M Marhold, P Mayer, M Schwarz, E Tomasich, A Lukas, ... PloS one 14 (1), e0210859, 2019 | 20 | 2019 |
| Whole body vibration therapy on a treatment bed as additional means to treat postprostatectomy urinary incontinence R Crevenna, F Cenik, M Margreiter, M Marhold, TS Komanadj, M Keilani Wien Med Wochenschr 167 (5-6), 139-141, 2017 | 19 | 2017 |
| 165MO Trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients (pts) with active brain metastases: primary outcome analysis from the TUXEDO-1 trial R Bartsch, AS Berghoff, J Furtner, M Marhold, ES Bergen, S Roider-Schur, ... Annals of Oncology 33, S198, 2022 | 18 | 2022 |
| The prostate cancer landscape in Europe: Current challenges, future opportunities M Marhold, G Kramer, M Krainer, C Le Magnen Cancer Letters 526, 304-310, 2022 | 18 | 2022 |
| Pregnancy after breast cancer in young BRCA carriers: an international hospital-based cohort study M Lambertini, E Blondeaux, E Agostinetto, AS Hamy, HJ Kim, A Di Meglio, ... JAMA 331 (1), 49-59, 2024 | 12 | 2024 |
| Sarcopenia in cancer—a focus on elderly cancer patients M Marhold, T Topakian, M Unseld memo-Magazine of European Medical Oncology 14 (1), 20-23, 2021 | 10 | 2021 |
| Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—Results from an international, multicenter analysis coordinated by the AGMT Study Group SP Gampenrieder, V Dezentjé, M Lambertini, A de Nonneville, M Marhold, ... ESMO open 8 (1), 100747, 2023 | 7 | 2023 |
